AMGEN DRNAMGEN DRNAMGEN DRN

AMGEN DRN

No trades
See on Supercharts

Key facts today

Amgen Inc. (AMGN) and Eli Lilly have filed a lawsuit against the US Department of Health and Human Services, claiming the agency wrongly certified clinics for a federal drug discount program.
Amgen is recognized as a new competitor in the obesity drug market, entering the space alongside Viking Therapeutics.
Analyze the impactAnalyze the impact
Market capitalization
‪863.79 B‬BRL
0.00BRL
‪33.55 B‬BRL
‪139.91 B‬BRL
Beta (1Y)
−0.02

About Amgen Inc.


CEO
Robert A. Bradway
Website
Headquarters
Thousand Oaks
Founded
1980
ISIN
BRAMGNBDR004
FIGI
BBG002H1H201
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
AMGN5186584
Amgen Inc. 2.77% 01-SEP-2053
Yield to maturity
7.18%
Maturity date
Sep 1, 2053
AMGN5235280
Amgen Inc. 3.0% 15-JAN-2052
Yield to maturity
6.85%
Maturity date
Jan 15, 2052
US31162CS7
AMGEN 20/50
Yield to maturity
6.72%
Maturity date
Feb 21, 2050
AMGN5235282
Amgen Inc. 2.8% 15-AUG-2041
Yield to maturity
6.67%
Maturity date
Aug 15, 2041
US31162BP4
AMGEN 12/43
Yield to maturity
6.50%
Maturity date
May 15, 2043
US31162CR9
AMGEN 20/40
Yield to maturity
6.47%
Maturity date
Feb 21, 2040
AMGD
AMGEN 22/52
Yield to maturity
6.46%
Maturity date
Feb 22, 2052
US31162DG2
AMGEN 22/62
Yield to maturity
6.45%
Maturity date
Feb 22, 2062
US31162BZ2
AMGEN 15/45
Yield to maturity
6.34%
Maturity date
May 1, 2045
AMGN4437315
Amgen Inc. 4.563% 15-JUN-2048
Yield to maturity
6.34%
Maturity date
Jun 15, 2048
AMGN4436563
Amgen Inc. 4.663% 15-JUN-2051
Yield to maturity
6.28%
Maturity date
Jun 15, 2051

Explore more bonds